Retired lab manager Peter Breaden, 69, from Churchtown, was successfully treated in 2010 on a Cancer Research UK clinical trial and he was invited to the University of Liverpool to announce the charity’s new programme at the institution.
Blood samples will be collected from people with newly-diagnosed diabetes for scientists to look for differences between those who later develop pancreatic cancer and those who don’t.
They will look for molecules in the samples, called biomarkers, that could form the basis for a way to identify people who could benefit from further cancer tests. Sampleswillbekeptinabiobank,toallowfor further studies which could help in future research.
Pancreatic cancer survival remains very low, with only 5-7% of patients surviving the disease for more than five years. Around 8,700 people die from pancreatic cancer each year in the UK, including around 930 people in the North West.
OTS News on Social Media